Kelly Shi
Stock Analyst at Jefferies
(3.06)
# 1,291
Out of 5,182 analysts
35
Total ratings
44.12%
Success rate
14.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Buy | $252 → $290 | $222.08 | +30.58% | 3 | Mar 16, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $6.96 | +29.31% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $83.85 | +45.50% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $70.26 | +9.59% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $134.94 | +9.68% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $36.34 | -22.95% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $21.26 | +106.96% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $5.46 | +174.73% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.08 | +543.56% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.17 | +170.79% | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $19 | $39.46 | -51.85% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $9.07 | +131.53% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.11 | +75.27% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $1.83 | +227.87% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $97.74 | -17.13% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $30.04 | +16.51% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.86 | +1,158.74% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $16.66 | -3.96% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $19.01 | +5.21% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.67 | +5,532.33% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.59 | +282.63% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.40 | +1,025.00% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $3.51 | +840.17% | 1 | Mar 8, 2021 |
Ascendis Pharma
Mar 16, 2026
Assumes: Buy
Price Target: $252 → $290
Current: $222.08
Upside: +30.58%
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.96
Upside: +29.31%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $83.85
Upside: +45.50%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $70.26
Upside: +9.59%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $134.94
Upside: +9.68%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $36.34
Upside: -22.95%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $21.26
Upside: +106.96%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $5.46
Upside: +174.73%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.08
Upside: +543.56%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.17
Upside: +170.79%
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $39.46
Upside: -51.85%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $9.07
Upside: +131.53%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.11
Upside: +75.27%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $1.83
Upside: +227.87%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $97.74
Upside: -17.13%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $30.04
Upside: +16.51%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.86
Upside: +1,158.74%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $16.66
Upside: -3.96%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $19.01
Upside: +5.21%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.67
Upside: +5,532.33%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.59
Upside: +282.63%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.40
Upside: +1,025.00%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $3.51
Upside: +840.17%